Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CONTROL OF CARBON DIOXIDE TRANSFER IN OXYGENATOR FOR EXTRACORPOREAL BLOOD GAS EXCHANGE
Document Type and Number:
WIPO Patent Application WO/2023/239282
Kind Code:
A1
Abstract:
A method for controlling carbon dioxide [CO2] removal in a device (5) for extracorporeal blood gas exchange is disclosed. The device (5) comprises an oxygenator (21) including a membrane (23) acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator. The method comprises the steps of adding (S1) CO2 to the sweep gas flow upstream of the oxygenator (21) to control a degree of CO2 removal from the bloodstream by the oxygenator, determining (S2) a measure of CO2 removal by the oxygenator (21) based on a difference [ΔCCO2blood] between a measure of a pre- oxygenator content of CO2 [CCO2in] in the bloodstream upstream of the oxygenator (21) and an estimate of a post-oxygenator content of CO2 [CCO2out] in the bloodstream downstream of the oxygenator (21), and utilizing (S3) the measure of CO2 removal for improved regulation of the CO2 addition to the sweep gas flow.

Inventors:
LARSSON ÅKE (SE)
Application Number:
PCT/SE2023/050561
Publication Date:
December 14, 2023
Filing Date:
June 05, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MAQUET CRITICAL CARE AB (SE)
International Classes:
A61M1/16
Foreign References:
US20210113755A12021-04-22
US20200353146A12020-11-12
EP3733225A12020-11-04
US20150034082A12015-02-05
Attorney, Agent or Firm:
ZACCO SWEDEN AB (SE)
Download PDF:
Claims:
CLAIMS

1 . A method for controlling carbon dioxide [CO2] removal in a device (5) for extracorporeal blood gas exchange, wherein the device (5) comprises an oxygenator (21) including a membrane (23) acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator, comprising the steps of: adding (S1) CO2 to the sweep gas flow upstream of the oxygenator (21) to control a degree of CO2 removal from the bloodstream by the oxygenator, determining (S2) a measure of CO2 removal by the oxygenator (21) based on a difference [ACCO2biood] between a measure of a pre-oxygenator content of CO2 [CCO2in] in the bloodstream upstream of the oxygenator (21) and an estimate of a post-oxygenator content of CO2 [CCO2out] in the bloodstream downstream of the oxygenator (21), and utilizing (S3) the measure of CO2 removal for regulation of the CO2 addition to the sweep gas flow.

2. The method of claim 1 , wherein the step of utilizing the measure of CO2 removal for regulation of the addition of CO2 to the sweep gas flow comprises: presenting (S3a) the measure of CO2 removal to an operator of the device (5) as decision support in manual adjustment of the addition of CO2 to the sweep gas flow, and/or presenting (S3b), to the operator, a recommendation for adjustment of the addition of CO2 to the sweep gas flow, based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator, and/or automatically regulating (S3c) the addition of CO2 to the sweep gas flow based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator.

3. The method of claim 1 or 2, wherein the measure of CO2 removal is determined from pre-oxygenator measurements of partial pressures of CO2 [PC02jn] and 02 [P02jn] in the bloodstream upstream of the oxygenator (21), and postoxygenator measurements of fractions of CO2 [FCO2out] and 02 [FO2out] in the sweep gas flow downstream of the oxygenator (21). 4. The method of any of the preceding claims, comprising the steps of: measuring (S2a) a pre-oxygenator partial pressure of CO2 [PC02jn] in the bloodstream upstream of the oxygenator (21), measuring (S2b) a pre-oxygenator partial pressure of 02 [P02jn] in the bloodstream upstream of the oxygenator (21), measuring (S2c) a post-oxygenator fraction of CO2 [FCO2out] in the sweep gas flow downstream of the oxygenator (21), measuring (S2d) a post-oxygenator fraction of 02 [FO2out] in the sweep gas flow downstream of the oxygenator (21), estimating (S2e) a post-oxygenator partial pressure of 002 [PCO2out] and a post-oxygenator partial pressure of 02 [PO2out] in the bloodstream downstream of the oxygenator (21) based on FCO2out and FO2out, and determining (S2i) the difference ACCO2biood between CC02jn and CC020ut based on PCO2in, P02in, PCO2out and PO2out.

5. The method of claim 4, comprising the steps of: measuring or estimating (S2g) a pre-oxygenator temperature [T .biood] of blood in the bloodstream upstream of the oxygenator (21), measuring or estimating (S2h) a post-oxygenator temperature [Tout,biood] of blood in the bloodstream downstream of the oxygenator (21), and determining (S2i) the difference ACCO2biood between CC02jn and CCO2out based on PCO2in, P02in, Tin,biood, PCO2out, PO2out and Tout.biood-

6. The method of claim 5, comprising the steps of: measuring or estimating (S2h) a haemoglobin content [Hb] of blood in the bloodstream through of the oxygenator (21), and determining (S2i) the difference ACCO2biood between CC02jn and CCO2out based on PCO2in, P02in, Tin,biood, PCO2out, PO2out, Tout,biood, and Hb.

7. The method of claim 6, comprising the steps of: calculating a net C02 exchange [VC02net] over the membrane (23) based on ACCO2biood, and utilizing VC02net as the measure of C02 removal. The method of any of the previous claims, further comprising the steps of: receiving a target value for the measure of CO2 removal, and automatically regulating the addition of CO2 to the sweep gas flow so as to reach and/or maintain the target value for the measure of CO2 removal. The method of claim 8, wherein the device (5) is connected to a patient (3) who is also connected to a mechanical ventilator (7) for mechanically ventilating the patient (3) through the supply of breathing gas to the lungs of the patient, and wherein the target value is set to zero in order to evaluate a ventilatory treatment provided by the mechanical ventilator (7) and/or a lung function of the patient (3). A computer program for controlling carbon dioxide [CO2] removal in a device (5) for extracorporeal blood gas exchange, wherein the device (5) comprises an oxygenator (21) including a membrane (23) acting as a gas-liquid barrier enabling CO2 content to pass from a bloodstream flowing through the oxygenator (21) to a sweep gas flow flowing through the oxygenator, the computer program comprising computer-readable instructions which, when executed by a control computer (27), causes the method of any of the previous claims to be performed. A computer program product comprising a non-transitory memory hardware device storing a computer program for controlling carbon dioxide [CO2] removal in a device (5) for extracorporeal blood gas exchange, wherein the device (5) comprises an oxygenator (21) including a membrane (23) acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator, the computer program comprising computer-readable instructions which, when executed by a control computer (27), causes the method of any of the claims 1 to 9 to be performed. A system (1) for controlling carbon dioxide [CO2] removal in a device (5) for extracorporeal blood gas exchange, wherein the device (5) comprises an oxygenator (21) including a membrane (23) acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator, the system (1) further comprising a sweep gas regulator (25) for adding CO2 to the sweep gas flow upstream of the oxygenator (21) in order to control a degree of CO2 removal from the bloodstream by the oxygenator (21), and at least one control computer (27) configured to: determine a measure of CO2 removal by the oxygenator (21) based on a difference [ACCO2biood] between a measure of a pre-oxygenator content of CO2 [CCO2in] in the bloodstream upstream of the oxygenator (21) and an estimate of a post-oxygenator content of CO2 [CCO2out] in the bloodstream downstream of the oxygenator (21), and utilizing the measure of CO2 removal for regulation of the CO2 addition to the sweep gas flow.

13. The system (1) of claim 12, wherein the at least one control computer (27) is configured to utilize the measure of CO2 removal for regulation of the CO2 addition to the sweep gas flow by: causing the measure of CO2 removal to be presented to an operator of the device (5) as decision support in manual adjustment of the addition of CO2 to the sweep gas flow, and/or causing a recommendation for adjustment of the addition of CO2 to the sweep gas flow to be presented to an operator of the device (5), which recommendation is based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator, and/or automatically regulating the addition of CO2 to the sweep gas flow based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator.

14. The system (1) of claim 12 or 13, wherein the control computer (27) is configured to determine the measure of CO2 removal from pre-oxygenator measurements of partial pressures of CO2 [PC02jn] and 02 [P02jn] in the bloodstream upstream of the oxygenator (21), and post-oxygenator measurements of fractions of CO2 [FCO2out] and 02 [FO2out] in the sweep gas flow downstream of the oxygenator (21). The system (1 ) of any of the claims 9 to 11 , wherein the control computer

(27) is configured to: receive a measurement of a pre-oxygenator partial pressure of CO2 [PCO2jn] in the bloodstream upstream of the oxygenator (21), receive a measurement of a pre-oxygenator partial pressure of 02 [P02jn] in the sweep gas flow upstream of the oxygenator (21), receive a measurement of a post-oxygenator fraction of CO2 [FCO2out] in the sweep gas flow downstream of the oxygenator (21), receive a measurement of a post-oxygenator fraction of 02 [FO2out] in the sweep gas flow downstream of the oxygenator (21), estimate a post-oxygenator partial pressure of 002 [PCO2out] and a postoxygenator partial pressure of 02 [PO2out] in the bloodstream downstream of the oxygenator (21) based on FCO2out and FO2out, and determine the difference ACCO2biood between CC02jn and CC020ut based on PCO2in, P02in, PC020ut, and PO2out. The system (1) of claim 15, wherein the control computer (27) is configured to: estimate or receive a measurement of a pre-oxygenator temperature [T .biood] of blood in the bloodstream upstream of the oxygenator (21), estimate or receive a measurement of a post-oxygenator temperature [Tout, blood] of blood in the bloodstream downstream of the oxygenator (21), and determine the difference ACCO2biood between CC02in and CCO2out based on PCO2in, PO2in, Tn, blood, PC020ut, P020ut and Tout, blood ■ The system (1) of claim 16, wherein the control computer (27) is configured to: estimate or receive a measurement of a haemoglobin content [Hb] of blood in the bloodstream through of the oxygenator (21), and determine the difference ACCO2biood between CC02jn and CCO2out based on PC02jn, P02jn, Tin, blood, PCO2out, PO2out, Tout, blood, and Hb. 18. The system (1) of claim 17, wherein the control computer (27) is configured to: calculate a net CO2 exchange [VCO2net] over the membrane (23) based on ACCO2biood, and - utilize VCO2net as the measure of CO2 removal.

19. The system (1) of any of the claims 12 to 18, wherein the control computer (27) is configured to: receive a target value for the measure of CO2 removal, and - automatically regulating the addition of CO2 to the sweep gas flow so as to reach and/or maintain the target value.

20. The system (1) of any of the claims 12 to 19, wherein the device (5) is connected to a patient (3) who is also connected to a mechanical ventilator (7) for mechanically ventilating the patient through the supply of breathing gas to the lungs of the patient, and wherein the target value is set to zero in order to evaluate a ventilatory treatment provided by the mechanical ventilator (7) and/or a lung function of the patient.

Description:
CONTROL OF CARBON DIOXIDE TRANSFER IN OXYGENATOR FOR EXTRACORPOREAL BLOOD GAS EXCHANGE

TECHNICAL FIELD

The present disclosure relates to the field of extracorporeal blood gas exchange by use of an oxygenator for extracorporeal removal of carbon dioxide from the blood of a patient. In particular, the disclosure relates to a method for controlling carbon dioxide exchange over the oxygenator through addition of carbon dioxide to a sweep gas flow through the oxygenator.

BACKGROUND

Mechanical ventilators and medical devices for oxygenation and extracorporeal removal of CO2 from human blood are well known examples of intensive care equipment that are used to provide ventilatory and sometimes circulatory support to patients with reduced lung function.

Mechanical ventilators are used to provide respiratory treatment to patients through the supply of oxygen-containing breathing gas to the patient’s lungs, allowing CO2 to be removed from, and oxygen to be added to, the circulatory system of a patient through gas exchange within the lungs.

Historically, medical devices for extracorporeal removal of CO2 from human blood, often referred to as extracorporeal membrane oxygenation (ECMO) devices, have primarily been used to provide ventilatory and circulatory support to patients having reduced lung and/or heart function in situations where conventional and less invasive treatments, such as mechanical ventilation, have been insufficient. Lately, however, combined treatment by ECMO devices and mechanical ventilators have gained more and more interest from clinicians also in the treatment of patients suffering from less severe lung conditions. In an ECMO device, carbon dioxide rich blood is withdrawn from the patient and provided to an oxygenator that serves as an artificial lung by removing CO2 and adding oxygen to the blood before the oxygen-enriched blood is returned to the circulatory system of the patient. The removal of CO2 and the addition of oxygen is achieved by sweeping an oxygen-containing sweep gas flow through the oxygenator, allowing gas exchange between the blood and the sweep gas to take place over the oxygenator membrane.

The sweep gas flow is typically a flow of oxygen and/or air. The degree of CO2 removal by the oxygenator may, in this case, be controlled by regulating the sweep gas flow and/or the fraction of oxygen in the sweep gas flow, as described in e.g. US20150034082.

It is also known to add carbon dioxide to the sweep gas flow to adjust the degree of CO2 removal by the oxygenator without affecting the addition of oxygen to the blood of the patient. In particular, it allows an ongoing ventilatory treatment provided by the mechanical ventilator and/or a lung function of the patient to be evaluated by minimizing CO2 removal by the oxygenator with reduced risk of blood hyperventilation and improved pH control. Such an evaluation is often referred to as a weaning test since it is sometimes performed to assess the patient’s readiness to be weaned from the ECMO device and/or the mechanical ventilator.

Normally, in order to minimize CO2 removal by the oxygenator through addition of CO2 to the sweep gas flow, the clinician manually adjusts the addition of CO2 until a measured fraction of CO2 in the sweep gas flow upstream of the oxygenator equals a measured fraction of CO2 in the sweep gas flow downstream of the oxygenator. When the fraction of CO2 upstream the oxygenator matches the fraction of CO2 downstream the oxygenator, it is assumed that no CO2 removal takes place over the oxygenator.

However, this assumption is often erroneous due to, e.g., the so called Haldane effect, according to which oxygenation of blood causes displacement of CO2 from haemoglobin, thereby increasing the removal of CO2. Furthermore, the manual control of the addition of CO2 to the sweep gas flow increases the manual workload of the clinician and the risk of human errors in the treatment of the patient.

SUMMARY

It is an object of the present disclosure to present a method, a computer program and a system for solving or mitigating one or more of the above mentioned problems associated with the prior art.

It is a particular object of the present disclosure to present a method, a computer program and a system for improved control of addition of CO2 to an oxygenator sweep gas flow, both in terms of accuracy and automation.

This and other objects, which will become apparent in view of the detailed description following hereinafter, are achieved in accordance with a first aspect of the present disclosure by a method, a computer program and a system as set forth below.

According to this first aspect of the disclosure, there is provided a method for controlling CO2 removal in a device for extracorporeal blood gas exchange, wherein the device comprises an oxygenator including a membrane acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator. The method comprises the steps of: adding CO2 to the sweep gas flow upstream of the oxygenator to control a degree of CO2 removal from the bloodstream by the oxygenator, determining a measure of CO2 removal by the oxygenator based on a difference (ACCO2biood) between a measure of a pre-oxygenator content of CO2 (CC02j n ) in the bloodstream upstream of the oxygenator and an estimate of a postoxygenator content of CO2 (CCO2 ou t) in the bloodstream downstream of the oxygenator, and utilizing the measure of CO2 removal for improved regulation of the CO2 addition to the sweep gas flow. By determining the measure of CO2 removal as a difference ACCO2biood between a measure of CCO2j n in the bloodstream upstream of the oxygenator and an estimate of CCO2 O ut in the bloodstream downstream of the oxygenator, a more correct measure of CO2 removal can be obtained compared to a solution where CO2 addition is controlled, e.g., based on a difference between measured FCO2 upstream and downstream of the oxygenator. Thus, the proposed technique offers an accurate yet relatively non-complex approach for controlling a degree of CO2 removal by the oxygenator.

According to some embodiments, the step of utilizing the measure of CO2 removal for improved regulation of the addition of CO2 to the sweep gas flow comprises: presenting the measure of CO2 removal to an operator of the device as decision support in manual adjustment of the addition of CO2 to the sweep gas flow, and/or presenting, to the operator, a recommendation for adjustment of the addition of CO2 to the sweep gas flow, based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator, and/or automatically regulating the addition of CO2 to the sweep gas flow based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator.

By presenting the measure of CO2 removal to an operator of the device, improved manual regulation of the addition of CO2 can be obtained, allowing the operator to adjust the addition of CO2 to the sweep gas flow to obtain a desired degree of CO2 removal, e.g., zero CO2 removal.

Recommendations for adjustment of the addition of CO2 may, for example, be based on the sign and/or magnitude of ACCO2biood. In one example, the recommendation may be a recommendation for adjustment of a measured fraction of CO2 (FCO2 in ) in the sweep gas flow upstream of the oxygenator by a certain amount or to a recommended level.

Automatic regulation of the addition of CO2 may be performed based on the measure of CO2 removal and a set target value for CO2 removal. In particular, automatic regulation of CO2 removal may be advantageous in situations where no CO2 removal by the oxygenator is desired. In such a scenario, the CO2 addition may be regulated using a closed control loop striving to reach and/or maintain a ACCO2 b iood of zero.

According to some embodiments, the measure of CO2 removal is determined from pre-oxygenator measurements of partial pressures of CO2 (PC02j n ) and 02 (P02j n ) in the bloodstream upstream of the oxygenator, and post-oxygenator measurements of fractions of CO2 (FCO2 ou t) and 02 (FO2 ou t) in the gas sweep flow downstream of the oxygenator . Measurements of pre-oxygenator PCO2 and PO2 may be obtained by a standard blood gas analyser (BGA). A BGA is normally used during ECMO treatment and hence readily available at the bedside of the patient. By taking both pre-oxygenator and post-oxygenator 002 and 02 into account in the determination of the measure of 002 removal, the Haldane effect may be compensated for and a more reliable measure of 002 removal can be obtained.

The first aspect of the present disclosure hence represents a semi gas-based approach for determining a measure of 002 removal by the oxygenator, where bloodgas analysis of the bloodstream upstream of the oxygenator is combined with gas analysis of the sweep gas flow downstream of the oxygenator.

According to some embodiments, the method comprises the steps of: measuring a pre-oxygenator partial pressure of C02 (PC02j n ) in the bloodstream upstream of the oxygenator, measuring a pre-oxygenator partial pressure of 02 (P02j n ) in the bloodstream upstream of the oxygenator, measuring a post-oxygenator fraction of C02 (FCO2 ou t) in the sweep gas flow downstream of the oxygenator, measuring a post-oxygenator fraction of 02 (FO2 ou t) in the sweep gas flow downstream of the oxygenator, estimating a post-oxygenator partial pressure of 002 (PCO2 ou t) and a postoxygenator partial pressure of 02 (PO2 ou t) in the bloodstream downstream of the oxygenator based on FCO2 ou t and FO2 ou t, and determining the difference ACCO2biood between CC02j n and CC02 0 ut based on PCO2 in , P02 in , PC02 0 ut and PO2 ou t. The measure of the pre-oxygenator content of CO2 (CCO2j n ) in the bloodstream upstream of the oxygenator may be expressed as a function of PC02j n , P02j n , Tm, blood and Hbm, where Tm.biood is the temperature of the bloodstream upstream of the oxygenator and Hbm is the haemoglobin content of the bloodstream upstream of the oxygenator. Likewise, the estimate of the post-oxygenator content of CO2 (CCO2 ou t) may be expressed as a function of PCO2 ou t PO2 ou t, T ou t,biood and Hb ou t, where T ou t,biood is the temperature of the bloodstream downstream of the oxygenator and Hb ou t is the haemoglobin content of the bloodstream downstream of the oxygenator. Since Hbm can be assumed to correspond to Hb ou t, and since Tm.biood can be assumed to be relatively close to T ou t,biood, those quantities need not be taken into account in an approximate determination of the difference ACCO2biood between CC02j n and CCO2 O ut.

According to some embodiments, the method comprises the steps of: measuring or estimating a pre-oxygenator temperature (Tm.biood) of blood in the bloodstream upstream of the oxygenator, measuring or estimating a post-oxygenator temperature (T ou t,biood) of blood in the bloodstream downstream of the oxygenator , and determining the difference ACCO2biood between CCO2i n and CCO2 ou t based on PCO2in, PO2in, n, blood, PCO2 O ut, PO2 O ut and Tout, blood

By taking the pre-oxygenator and the post-oxygenator temperatures of the bloodstream into account in the determination of ACCO2biood, a more accurate measure of CO2 removal can be determined.

According to some embodiments, the method comprises the steps of: measuring or estimating a haemoglobin content (Hb) of blood in the bloodstream through of the oxygenator, and determining the difference ACCO2biood between CC02j n and CCO2 ou t based on PCO2jn, P02jn, Tin, blood, PCO2out, PO2out, Tout, blood, and Hb.

By measuring and taking Hb into account in the determination of ACCO2biood, the transfer of CO2 over the oxygenator membrane can be quantified and an actual net CO2 exchange, VCO2 ne t, in ml/min can be calculated and used as the measure of CO2 removal. This is advantageous in that a metric indicating actual CO2 removal in ml/min over the membrane can be presented to an operator of the device, or be used as a control parameter in manual, semi-automatic or automatic control of the sweep gas flow rate and/or an addition of CO2 to the sweep gas flow, in order to meet a set target value for net CO2 exchange.

Accordingly, the method may comprise the steps of: calculating a net CO2 exchange (VCO2 ne t) over the membrane based on

ACCO2 b iood, and utilizing VCO2 ne t as the measure of CO2 removal.

According to some embodiments, the method comprises the steps of: receiving a target value for the measure of CO2 removal, and automatically regulating the addition of CO2 to the sweep gas flow so as to reach and/or maintain the target value for the measure of CO2 removal.

According to some embodiments, the device is connected to a patient who is also connected to a mechanical ventilator for mechanically ventilating the patient through the supply of breathing gas to the lungs of the patient, wherein the target value is set to zero in order to evaluate a ventilatory treatment provided by the mechanical ventilator and/or a lung function of the patient.

The above mentioned features allow a so called weaning test of the patient to be accurately and automatically performed. By ensuring that the oxygenator does not participate in the removal of CO2 from the patient’s blood, the ventilatory treatment and/or the lung function of the patient can be reliably evaluated.

According to the first aspect of the disclosure, there is also provided a computer program for controlling CO2 removal in a device for extracorporeal blood gas exchange, wherein the device comprises an oxygenator including a membrane acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator. The computer program comprises computer-readable instructions which, when executed by a control computer, causes the above described method to be performed.

According to the first aspect of the disclosure, there is also provided a computer program product comprising a non-transitory memory hardware device storing a computer program for controlling CO2 removal in a device for extracorporeal blood gas exchange, wherein the device comprises an oxygenator including a membrane acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator The computer program comprises computer-readable instructions which, when executed by a control computer, causes the above described method to be performed.

According to the first aspect of the disclosure, there is also provided a system for controlling CO2 removal in a device for extracorporeal blood gas exchange, wherein the device comprises an oxygenator including a membrane acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator. The system further comprises a sweep gas regulator for adding CO2 to the sweep gas flow upstream of the oxygenator in order to control a degree of CO2 removal from the bloodstream by the oxygenator. The device further comprises at least one control computer configured to: determine a measure of CO2 removal by the oxygenator based on a difference (ACCO2biood) between a measure of a pre-oxygenator content of CO2 (CC02j n ) in the bloodstream upstream of the oxygenator and an estimate of a postoxygenator content of CO2 (CCO2 ou t) in the bloodstream downstream of the oxygenator, and utilizing the measure of CO2 removal for improved regulation of the CO2 addition to the sweep gas flow.

According to some embodiments, the at least one control computer is configured to utilize the measure of CO2 removal for improved regulation of the CO2 addition to the sweep gas flow by: causing the measure of CO2 removal to be presented to an operator of the device as decision support in manual adjustment of the addition of CO2 to the sweep gas flow, and/or causing a recommendation for adjustment of the addition of CO2 to the sweep gas flow to be presented to an operator of the device, which recommendation is based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator, and/or automatically regulating the addition of CO2 to the sweep gas flow based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator.

According to some embodiments, the control computer is configured to determine the measure of CO2 removal from pre-oxygenator measurements of partial pressures of CO2 (PC02j n ) and 02 (P02j n ) in the bloodstream upstream of the oxygenator, and post-oxygenator measurements of fractions of CO2 (FCO2 ou t) and 02 (F02 0 ut) in the gas sweep flow downstream of the oxygenator.

According to some embodiments, the control computer is configured to: receive a measurement of a pre-oxygenator partial pressure of 002 (PC02j n ) in the bloodstream upstream of the oxygenator, receive a measurement of a pre-oxygenator partial pressure of 02 (P02j n ) in the bloodstream upstream of the oxygenator, receive a measurement of a post-oxygenator fraction of 002 (FCO2 ou t) in the sweep gas flow downstream of the oxygenator, receive a measurement of a post-oxygenator fraction of 02 (FO2 ou t) in the sweep gas flow downstream of the oxygenator, estimate a post-oxygenator partial pressure of 002 (PCO2 ou t) and a postoxygenator partial pressure of 02 (PO2 ou t) in the bloodstream downstream of the oxygenator based on FCO2 ou t and FO2 ou t, and determine the difference ACCO2biood between CC02j n and CC02 0 ut based on PCO2 in , P02 in , PC02 0 ut, and PO2 ou t.

According to some embodiments, the control computer is configured to: estimate or receive a measurement of a pre-oxygenator temperature (Tm.biood) of blood in the bloodstream upstream of the oxygenator, estimate or receive a measurement of a post-oxygenator temperature (T ou t,biood) of blood in the bloodstream downstream of the oxygenator , and determine the difference ACCO2biood between CCO2j n and CCO2 ou t based on PC02j n , P02j n , Tin, blood, PCO2 O ut, P02 0 ut and Tout, blood-

According to some embodiments, the control computer is configured to: estimate or receive a measurement of a haemoglobin content (Hb) of blood in the bloodstream through of the oxygenator, and determine the difference ACCO2biood between CC02j n and CCO2 ou t based on PCO2jn, P02jn, Tin, blood, PCO2out, PO2out, Tout, blood, and Hb.

According to some embodiments, the control computer is configured to: calculate a net CO2 exchange (VCO2 ne t) over the membrane based on ACCO2 b iood, and utilize VCO2net as the measure of CO2 removal.

According to some embodiments, the control computer is configured to: receive a target value for the measure of CO2 removal, and automatically regulate the addition of CO2 to the sweep gas flow so as to reach and/or maintain the target value.

According to some embodiments, the device is connected to a patient who is also connected to a mechanical ventilator for mechanically ventilating the patient through the supply of breathing gas to the lungs of the patient, wherein the target value is set to zero in order to evaluate a ventilatory treatment provided by the mechanical ventilator and/or a lung function of the patient.

In is another object of the present disclosure to present a method, a computer program and a system for quantification of CO2 removal in an oxygenator for extracorporeal blood gas exchange, which method, computer program and system is advantageously used to further improve the control of addition of CO2 to an the oxygenator sweep gas flow.

This and other objects, which will become apparent in view of the detailed description following hereinafter, are achieved in accordance with a second aspect of the present disclosure by a method, a computer program and a system as set forth below.

According to this second aspect of the disclosure, there is provided a method for controlling CO2 removal in a device for extracorporeal blood gas exchange, wherein the device comprises an oxygenator including a membrane acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator. The method comprises the steps of: measuring a pre-oxygenator fraction of CO2 (FC02j n ) in the sweep gas flow upstream of the oxygenator, measuring a pre-oxygenator sweep gas flow rate (Vm) of the sweep gas flow upstream of the oxygenator, measuring a post-oxygenator fraction of CO2 (FCO2 ou t) in the sweep gas flow downstream of the oxygenator, measuring a post-oxygenator sweep gas flow rate (V ou t) of the sweep gas flow downstream of the oxygenator, and calculating a net CO2 exchange (VCO2 ne t) over the membrane based on measured FC02j n , Vm, FCO2 ou t and V ou t.

An effect of calculating the net CO2 exchange, VCO2 ne t, over the membrane is that a metric indicating actual CO2 removal in ml/min over the membrane can be presented to an operator of the device, or be used as a control parameter in manual, semi-automatic or automatic control of the sweep gas flow rate and/or an addition of CO2 to the sweep gas flow to meet a set target value for the net CO2 exchange. The proposed technique is advantageous in that it presents a purely gas based approach for determining actual CO2 removal by the oxygenator, without the need for blood gas analysis.

According to some embodiments, the method comprises the steps of: adding CO2 to the sweep gas flow upstream of the oxygenator to control a degree of CO2 removal from the bloodstream by the oxygenator, and utilizing VCO2 ne t as a measure of CO2 removal for improved regulation of the CO2 addition to the sweep gas flow. By utilizing the actual net CO2 exchange for regulation of CO2 addition to the sweep gas flow, an improved and more intuitive regulation of CO2 addition is achieved. In contrast to solutions where CO2 addition is controlled directly based on a difference in measured fractions of CO2 upstream and downstream of the oxygenator (or a difference between other surrogate parameters indicative of CO2 exchange over the membrane), the calculation of VCO2 ne t allows the actual effect of adjustments in CO2 addition to be visualized in terms of a volume of CO2 removal per time unit. Furthermore, in contrast to solutions according to prior art, it allows a non-zero target value for net CO2 removal to be set by the operator, whereby the CO2 addition can be manually, semi-automatically or automatically controlled to make the calculated VCO2 ne t value correspond to the set target value.

According to some embodiments, the step of utilizing the measure of CO2 removal for improved regulation of the addition of CO2 to the sweep gas flow comprises: presenting the measure of CO2 removal to an operator of the device as decision support in manual adjustment of the addition of CO2 to the sweep gas flow, and/or presenting, to the operator, a recommendation for adjustment of the addition of CO2 to the sweep gas flow, based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator, and/or automatically regulating the addition of CO2 to the sweep gas flow based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator.

According to some embodiments, the method comprises the steps of: measuring or estimating a pre-oxygenator fraction of at least one additional gas in the sweep gas flow upstream of the oxygenator, the at least one additional gas being one or more of water vapour (H2O), oxygen (02), nitrogen gas (N2), and an anaesthetic agent, and/or measuring or estimating a post-oxygenator fraction of the at least one additional gas in the sweep gas flow downstream of the oxygenator, and calculating a compensated pre-oxygenator sweep flow rate (V .comp) based on Vin, FCO2 in and the pre-oxygenator fraction of the at least one additional gas, and/or calculating a compensated post-oxygenator sweep flow rate (V ou t,com P ) based on Vout, FCO2 O ut and the post-oxygenator fraction of the at least one additional gas, and calculating VCO2 ne t based on at least one of V .comp and V ou t,com P .

By taking the composition of the sweep gas into account and compensating one or both of the pre- and post-oxygenator sweep flow rate measurements V in and V ou t based on a measured fraction of at least one additional gas in the sweep gas flow upstream and/or downstream the oxygenator, a more accurate value of VCO2 ne t can be obtained. The different and altering compositions of the sweep gas flow upstream and downstream of the oxygenator typically introduce errors in the flow measurements due to characteristics and calibration-related parameters of the flow sensors used for obtaining the measurements. By calculating compensated sweep flow rates Vj n ,com P and V ou t,com P , such errors can be eliminated or at least substantially mitigated.

According to some embodiments, the at least one additional gas comprises water vapour.

The high concentration of water vapour in the sweep gas flow downstream of the oxygenator causes several problems when it comes to flow and gas concentration measurements and comparisons in membrane oxygenators. By properly measuring or estimating the fraction of water vapour in the sweep gas flow, gas composition measurements and sweep gas flow rate measurements can be compensated based on the fraction of water vapour in the sweep gas flow upstream and/or downstream of the oxygenator. In particular for measurements of the sweep gas flow rate downstream of the oxygenator where humidity is high, the fraction of water vapour in the gas measured upon needs to be taken into account for more precise flow rate determination.

According to some embodiments, the method comprises the steps of: calculating a compensated pre-oxygenator fraction of CO2 (FCO2j n ,com P ) representing an estimate of a fraction of CO2 at a point of measurement of Vm, based on FC02j n and an estimated addition or removal of water vapour (AFH20in) to or from the sweep gas between the point of measurement of V in and a point of measurement of FC02j n , and/or calculating a compensated post-oxygenator fraction of CO2 (FCO2 O ut,com P ) representing an estimate of a fraction of CO2 at a point of measurement of V ou t, based on FCO2 ou t and an estimated addition or removal of water vapour (AFH2O O ut) to or from the sweep gas between the point of measurement of V ou t and a point of measurement of FCO2 ou t, and calculating VCO2 ne t based on at least one of FC02j n , comp and FCO2 O ut,com P .

For precise calculation of VCO2 ne t, not only the measured flow rates but also the measured fractions of CO2 may need to be compensated in order to accurately reflect the fractions of CO2 in the sweep gas flow measured by the flow sensors. In particular in a situation where a sidestream gas analyser is used for sampling sweep gas from a sweep gas outlet line of the oxygenator, the fraction of CO2 in the sweep gas samples measured upon may deviate substantially from the fraction of CO2 in the sweep gas outlet line due to removal of water vapour from the gas samples to be measured upon. For example, it may be desired to remove water vapour from the gas samples prior to FCO2 measurements in order to avoid condensation of water vapour in the gas analyser. The difference AFH2O ou t in fraction of H2O between sweep gas in the outlet line (where post-oxygenator flow measurements take place) and the sweep gas samples measured upon by the sidestream gas analyser introduces a discrepancy between measured FCO2 ou t and the actual fraction of CO2 at the point of flow measurements. This discrepancy can be eliminated or at least substantially mitigated by calculating a compensated FCO2 O ut,com P based on FCO2 ou t and an estimated addition or removal of water vapour, AFH2O ou t, to or from the sweep gas between the point of measurement of V ou t and a point of measurement of FCO2 O ut. The same applies on the upstream-side of the oxygenator although the difference AFH20j n in fraction of H2O between sweep gas in the sweep gas inlet line of the oxygenator and the sweep gas samples measured upon by the sidestream gas analyser normally is considerably smaller than on the downstream-side of the oxygenator due to the relatively dry pre-oxygenator sweep gas flow.

For example, in some embodiments, the estimated addition or removal of water vapour, AFH2O O ut, to or from the sweep gas between a point of measurement of V ou t in the sweep gas outlet line and a point of measurement of FCO2 ou t in a sidestream gas analyser may be calculated based on a measured post-oxygenator temperature (Tout, gas) of the sweep gas flow downstream of the oxygenator, a measured or estimated post-oxygenator relative humidity (RH ou t) of the sweep gas flow downstream of the oxygenator, a measured or estimated reference temperature (Tret) at or close to the point of measurement of FCO2 ou t, and a measured or estimated reference relative humidity (RH re f) at or close to the point of measurement of FCO2 O ut. Likewise, the estimated addition or removal of water vapour, AFH20j n , to or from the sweep gas between a point of measurement of V in in the sweep gas inlet line and a point of measurement of FC02j n in a sidestream gas analyser may be calculated based on a measured pre-oxygenator temperature (Tm.gas) of the sweep gas flow upstream of the oxygenator, a measured or estimated pre-oxygenator relative humidity (RHm) of the sweep gas flow upstream of the oxygenator, a measured or estimated reference temperature (T re f) at or close to the point of measurement of FC02j n , and a measured or estimated reference relative humidity (RHref) at or close to the point of measurement of FC02j n . For example, when removing water vapour from the sampled sweep gas by conditioning the samples using, e.g., a Nation drying tube prior to providing the sweep gas samples to the sidestream analyser for FCO2 measurements, the reference relative humidity, RH re f, typically corresponds to the ambient RH surrounding the Nation drying tube. In other examples, when removing water vapour from the sampled sweep gas by conditioning the samples using, e.g., silica gel prior to providing the sweep gas samples to the sidestream analyser, the reference relative humidity, RH re f, can be assumed to be zero or near zero.

According to some embodiments, Vm, comp is calculated based on FCO2j n ,comp and the pre-oxygenator fraction of the at least one additional gas. According to some embodiments, V ou t,comp is calculated based on FCO2 O ut,com P and the post-oxygenator fraction of the at least one additional gas.

By calculating the compensated sweep gas flow rates from the compensated fractions of CO2 and, optionally, from compensated measurements of fractions of additional gas, instead of relying on the measured fractions, an even higher accuracy in the sweep gas flow rate measurements and hence in the determination of VCO2net can be obtained.

According to some embodiments, the method comprises the steps of: receiving a target value for the measure of CO2 removal, and automatically regulating the addition of CO2 to the sweep gas flow so as to reach and/or maintain the target value for the measure of CO2 removal.

According to some embodiments, the device for extracorporeal blood gas exchange is connected to a patient who is also connected to a mechanical ventilator for mechanically ventilating the patient through the supply of breathing gas to the lungs of the patient, wherein the target value is selected to facilitate evaluation of a ventilatory treatment provided by the mechanical ventilator and/or a lung function of the patient, e.g., by selecting a target value corresponding to zero or near zero CO2 removal.

This facilitates efficient combinatory treatment of the patient by the oxygenator and the ventilator since the quantification of net CO2 removal by the oxygenator allows a clinician to better understand the effects of the ongoing treatment and facilitates diagnosis of the current lung status of the patient. Furthermore, it allows a so called weaning test of the patient to be accurately and automatically performed since the ventilatory treatment provided by the ventilator and/or the lung function of the patient can be reliably evaluated by setting a target value for net CO2 removal by the oxygenator to a zero or near zero value.

According to the second aspect of the disclosure, there is also provided a computer program for controlling CO2 removal in a device for extracorporeal blood gas exchange, wherein the device comprises an oxygenator including a membrane acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator. The computer program comprises computer-readable instructions which, when executed by a control computer, cause the above described method to be performed. According to the second aspect of the disclosure, there is also provided a computer program product comprising a non-transitory memory hardware device storing a computer program for controlling CO2 removal in a device for extracorporeal blood gas exchange, wherein the device comprises an oxygenator including a membrane acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator. The computer program comprising computer-readable instructions which, when executed by a control computer, cause the above described method to be performed.

According to the second aspect of the disclosure, there is also provided a system for controlling CO2 removal in a device for extracorporeal blood gas exchange, wherein the device comprises an oxygenator including a membrane acting as a gas-liquid barrier enabling CO2 transfer between a bloodstream and a sweep gas flow through the oxygenator. The system further comprises at least one control computer configured to: receive a measurement of a pre-oxygenator fraction of CO2 (FC02j n ) in the sweep gas flow upstream of the oxygenator, receive a measurement of a pre-oxygenator sweep gas flow rate of the sweep gas flow upstream of the oxygenator, receive a measurement of a post-oxygenator fraction of CO2 (FCO2 ou t) in the sweep gas flow downstream of the oxygenator, receive a measurement of a post-oxygenator sweep gas flow rate of the sweep gas flow downstream of the oxygenator, and calculate a net CO2 exchange (VCO2 ne t) over the membrane based on measured FC02j n , Vm, FCO2 ou t and V ou t.

According to some embodiments, the system comprises a gas regulator for adding CO2 to the sweep gas flow upstream of the oxygenator in order to reduce a degree of CO2 removal from the bloodstream by the oxygenator, wherein the control computer is configured to utilize VCO2 ne t as a measure of CO2 removal for improved regulation of the CO2 addition to the sweep gas flow. According to some embodiments, the control computer is configured to utilize the measure of CO2 removal for improved regulation of the addition of CO2 to the sweep gas flow by: causing the measure of CO2 removal to be presented to an operator of the device as decision support in manual adjustment of the addition of CO2 to the sweep gas flow, and/or causing a recommendation for adjustment of the addition of CO2 to the sweep gas flow to be presented to an operator of the device, based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator, and/or automatically regulating the addition of CO2 to the sweep gas flow based on the measure of CO2 removal.

According to some embodiments, the control computer is configured to: estimate or receive a measurement of a pre-oxygenator fraction of at least one additional gas in the sweep gas flow upstream of the oxygenator, the at least one additional gas being one or more of water vapour (H2O), oxygen (02), nitrogen gas (N2), and an anaesthetic agent, and/or estimate or receive a measurement of a post-oxygenator fraction of the at least one additional gas in the sweep gas flow downstream of the oxygenator, and calculate a compensated pre-oxygenator sweep flow rate (V .comp) based on V , FCO2 in and the pre-oxygenator fraction of the at least one additional gas, and/or calculate a compensated post-oxygenator sweep flow rate (V ou t,com P ) based on Vout, FC02 0 ut and the post-oxygenator fraction of the at least one additional gas, and calculate VCO2 ne t based on at least one of Vm.comp and V ou t,comp.

According to some embodiments, the at least one additional gas comprises water vapour.

According to some embodiments, the control computer is configured to: calculate a compensated pre-oxygenator fraction of CO2 (FCO2j n ,comp) representing an estimate of a fraction of CO2 at a point of measurement (P1 ) of V , based on FCO2 and an estimated addition or removal of water vapour (AFH20in) to or from the sweep gas between the point of measurement (P1) of Vm and a point of measurement (P2) of FC02j n , and/or calculate a compensated post-oxygenator fraction of CO2 (FCO2 O ut,com P ) representing an estimate of a fraction of CO2 at a point of measurement (P3) of Vout, based on FCO2 ou t and an estimated addition or removal of water vapour (AFH2O O ut) to or from the sweep gas between the point of measurement (P3) of Vout and a point of measurement (P4) of FCO2 ou t, and calculate VCO2 ne t based on at least one of FCO2j n ,comp and FCO2 O ut,com P .

According to some embodiments, the control computer is configured to calculate an estimated addition or removal of water vapour, AFH2O ou t, to or from the sweep gas between a point of measurement of V ou t in the sweep gas outlet line and a point of measurement of FCO2 ou t in a sidestream gas analyser based on a measured postoxygenator temperature (Tout, gas) and a measured post-oxygenator relative humidity (RHout) of the sweep gas flow downstream of the oxygenator, and a measured or estimated reference temperature (T re t) and a measured or estimated reference relative humidity (RH re t) at or close to the point of measurement of FCO2 ou t.

Likewise, the control computer may be configured to calculate an estimated addition or removal of water vapour, AFH20j n , to or from the sweep gas between a point of measurement of Vm in the sweep gas inlet line and a point of measurement of FCO2 in in a sidestream gas analyser based on a measured pre-oxygenator temperature (Tm.gas) and a measured or estimated pre-oxygenator relative humidity (RH ) of the sweep gas flow upstream of the oxygenator, and a measured or estimated reference temperature (T re f) and a measured or estimated reference relative humidity (RH re f) at or close to the point of measurement of FCO2 .

According to some embodiments, Vm.comp is calculated based on FCO2j n ,com P and the pre-oxygenator fraction of the at least one additional gas. According to some embodiments, V ou t,com P is calculated based on FCO2 O ut,com P and the post-oxygenator fraction of the at least one additional gas.

According to some embodiments, the control computer is configured to: receive a target value for the measure of CO2 removal, and regulating the addition of CO2 to the sweep gas flow so as to reach and/or maintain the target value for the measure of CO2 removal.

According to some embodiments, the device for extracorporeal blood gas exchange is connected to a patient who is also connected to a mechanical ventilator for mechanically ventilating the patient through the supply of breathing gas to the lungs of the patient, wherein the target value is selected to facilitate evaluation of a ventilatory treatment provided by the mechanical ventilator and/or a lung function of the patient, e.g., by selecting a target value corresponding to zero or near zero CO2 removal.

More advantageous features of the method, computer program and system of the first and second aspects of the present disclosure will be described in the detailed description following hereinafter.

BRIEF DESCRIPTION OF THE DRAWINGS

The present invention will become more fully understood from the detailed description provided hereinafter and the accompanying drawings, which are given by way of non-limiting illustration only. In the different drawings, same reference numerals correspond to the same element.

Fig. 1 illustrates an exemplary non-limiting embodiment of an ECMO-vent system for extracorporeal removal of CO2 from the blood of a patient undergoing mechanical ventilation.

Fig. 2 illustrates an exemplary non-limiting embodiment of an ECMO device of the ECMO-vent system in Fig. 1.

Figs.3-5 are flow charts illustrating an exemplary non-limiting embodiment of a method for controlling CO2 removal in and by the ECMO device, according to a first aspect of the disclosure. Fig. 6 is a flowchart illustrating an exemplary non-limiting embodiment of a method for controlling CO2 removal in and by the ECMO device, according to a second aspect of the disclosure.

DETAILED DESCRIPTION

The present disclosure relates to the field of extracorporeal blood gas exchange by use of an oxygenator for extracorporeal removal of carbon dioxide (CO2) from the blood of a patient. In particular, the disclosure relates to a method, a computer program and a system for improved control of CO2 removal by the oxygenator through addition of CO2 to a sweep gas flow through the oxygenator.

The invention will be described in the context of a combined system for extracorporeal blood gas exchange via a membrane oxygenator during lung protective ventilation of the patient using a mechanical ventilator. However, it should be appreciated that the proposed control of the oxygenator is not dependent on the ventilator and that the operation of the oxygenator does not require the presence of a ventilator.

Fig. 1 illustrates a system 1 for combined mechanical ventilation of the lungs of a patient 3 and extracorporeal removal of CO2 from the blood of the patient 3. The system 1 will hereinafter referred to as an ECMO-vent system. ECMO (extracorporeal membrane oxygenation) is one of several terms used for extracorporeal blood gas exchange where blood is pumped outside the body of a treated patient to a device, sometimes referred to as a heart-lung machine, which removes CO2 and sends oxygen-enriched blood back to the patient. Other terms that are frequently used in the art for the same or similar treatments are ECLA (extracorporeal lung assist), ECCO2R (extracorporeal CO2 removal), ECLS (extracorporeal life support) and ECGE (extracorporeal membrane gas-exchange), all of which are encompassed by the term ECMO as used herein.

The ECMO-vent system 1 comprises a device 5, hereinafter referred to as an ECMO device, for extracorporeal removal of CO2 from the blood of the patient 3, and a mechanical ventilator 7 for mechanically ventilating the patient 3 through the supply of breathing gas to the lungs of the patient.

The ventilator 7 comprises or is connected to a source of pressurised breathing gas (not shown), which breathing gas is supplied to the patient 3 via a patient circuit 9. In this example, the patient circuit 9 comprises an inspiratory line 11 for conveying a flow of breathing gas to the patient 3, and an expiratory line 13 for conveying a flow of exhalation gas exhaled by the patient away from the patient. The inspiratory line 11 and the expiratory line 13 are connected to each other via a so called Y-piece 15 which, in turn, is connected to the patient 3 via a common line 17.

The ECMO device 5 is configured to provide ECMO treatment to the patient 3 by generating an extracorporeal flow of blood from the patient 3, oxygenating the blood through extracorporeal blood gas exchange in which CO2 is removed from, and oxygen (02) added to, the extracorporeal blood flow, and returning the oxygen- enriched blood to the patient 3.

To generate the flow of blood to and from the patient 3, the ECMO device 5 may comprise a blood flow generator (not shown), typically in form of one or several roller, turbine and/or centrifugal pumps. The blood flow generator generates a flow of blood through a tubing system forming a blood flow channel 19 of the ECMO device 5, where parts of the channel may be heated to maintain a desired temperature of the blood when returned to the patient 3.

The blood gas exchange, including blood oxygenation and CO2 removal, takes place in a membrane oxygenator 21 of the ECMO device 5, in which an oxygencontaining sweep gas flow interacts with the blood in the blood flow channel 19 via a membrane 23 of the oxygenator 21. The membrane 23 acts as a gas-liquid barrier enabling transfer of CO2 and 02 content between the bloodstream flowing through the oxygenator 21 on a liquid-side of the membrane 23 and the sweep gas flow flowing through the oxygenator 21 on a gas-side of the membrane 23.

The sweep gas flow is generated by a sweep gas generator 25 connected to one or more sweep gas sources, typically including one or both of an oxygen source and a source of compressed air. According to the principles of the present disclosure, the sweep gas generator 25 is further connected to a CO2 source in order to control the degree of CO2 removal over the oxygenator 21 through addition of CO2 to the sweep gas flow. The sweep gas generator 23 is configured to deliver a controllable sweep gas composition to the oxygenator 21 at a controllable sweep gas flow rate.

The composition and, optionally, the flow rate of the sweep gas generated by the sweep gas generator 23 may be automatically controlled by a controller or control computer 27 of the ECMO device 5 based on set target values and sensor data obtained by various sensors 29, 31 of the ECMO device 5. In particular, the control computer 27 of the ECMO device 5 may be configured to automatically control an addition of CO2 to a sweep gas flow comprising any or both of oxygen and air, based on a set target for a measure of CO2 removal by the oxygenator 21.

Hereinafter, the sweep gas flow upstream of the oxygenator 21 (i.e., before the oxygenator from the sweep gas’ point of view) will be referred to as an input sweep gas flow or a pre-oxygenator sweep gas flow, and the sweep gas flow downstream of the oxygenator 21 (i.e., after the oxygenator from the sweep gas’ point of view) will be referred to as an output sweep gas flow or a post-oxygenator sweep gas flow. The input sweep gas flow flows from the sweep gas generator 25 to the oxygenator 21 via a sweep gas inlet line 33a of the ECMO device 5, and the output sweep gas flow flows from the oxygenator 21 to atmosphere or an evacuation or recirculation system via a sweep gas outlet line 33b. In most configurations, ECMO systems are open systems, meaning that the post oxygenator sweep gas flow is allowed to escape into the ambient. In some cases, especially when anesthetic agents are added to the sweep gas flow, a closed or semi closed (sweep) gas control system can be envisioned, similar to gas control systems often used in anesthesia machines.

Likewise, the bloodstream upstream of the oxygenator 21 (i.e., before the oxygenator from the bloodstream’s point of view) may hereinafter be referred to as an input bloodstream or pre-oxygenator bloodstream, and the bloodstream downstream of the oxygenator 21 (i.e., after the oxygenator from the bloodstream’s point of view) may be referred to as an output bloodstream or post-oxygenator bloodstream. The input bloodstream flows from the patient 3 to the oxygenator 21 via a bloodstream inlet line 19a of the ECMO device 5, and the output bloodstream flows from the oxygenator 21 and back to the patient 3 via a bloodstream outlet line 19b of the ECMO device 5.

With reference now made to Fig. 2, the sensors 29, 31 of the ECMO device 5 may comprise: a pre-oxygenator flow rate sensor 29a for measuring a flow rate of the input sweep gas flow, Vm. The pre-oxygenator flow rate sensor 29a is a mainstream flow sensor, meaning that it is configured to measure the flow rate of the sweep gas flowing in the sweep gas inlet line 33a. The pre-oxygenator flow measurements obtained by the pre-oxygenator flow rate sensor 29a take place at a pre-oxygenator point of flow measurement denoted P1 in the sweep gas inlet line 33a. a pre-oxygenator gas analyser 29b for measuring a fraction of at least CO2 in the input sweep gas flow, FC02j n . The pre-oxygenator gas analyser 29b may also be configured to measure a fraction of one or more additional gases selected from the group consisting of oxygen (02), nitrogen gas (N2), and anaesthetic agents. In this exemplary embodiment, the pre-oxygenator gas analyser 29b is a so called sidestream gas analyser that is configured to withdraw sweep gas samples from the sweep gas inlet line 33a, and measure the fraction of CO2 and, optionally, the fraction of the at least one additional gas in the sweep gas samples at a pre-oxygenator point of CO2 measurement denoted P2. The pre-oxygenator point of CO2 measurement P2 is separated in distance from the point of pre-oxygenator sweep gas flow rate measurements, P1, at least by the length of a pre-oxygenator sample line 34a. In other embodiments, the pre-oxygenator gas analyser 29b may be a so called mainstream gas analyser that is configured to measure the fraction of CO2 and, optionally, the fraction of the at least one additional gas within the sweep gas inlet line 33a. In some embodiments, the pre-oxygenator gas analyser comprises at least a CO2 sensor and an 02 sensor for measuring a fraction of CO2 and 02, respectively, in the sweep gas samples. In some embodiments, the C02 sensor is a non-dispersive infrared (NDIR) C02 sensor. In some embodiments, the 02 sensor is a paramagnetic or electrochemical 02 sensor. a pre-oxygenator temperature sensor 29c for measuring a temperature of the input sweep gas, Tj n , g as. a pressure sensor 29d for measuring a sweep gas circuit pressure, P gas , substantially corresponding to the sweep gas pressure in the gas inlet line 33a. a post-oxygenator flow rate sensor 31a for measuring a flow rate of the output sweep gas flow, V ou t. The post-oxygenator flow rate sensor 31a is a mainstream flow sensor, meaning that it is configured to measure the flow rate of the sweep gas flowing in the sweep gas outlet line 33b. The post-oxygenator flow measurements obtained by the post-oxygenator flow rate sensor 31a take place at a post-oxygenator point of flow measurement denoted P3 in the sweep gas outlet line 33b. a post-oxygenator gas analyser 31b for measuring a fraction of at least CO2 in the output sweep gas flow, FCO2 ou t. The post-oxygenator gas analyser 31b may also be configured to measure a fraction of one or more additional gases selected from the group consisting of oxygen (02), nitrogen gas (N2), and anaesthetic agents. In this exemplary embodiment, the post-oxygenator gas analyser 31b is a so called sidestream gas analyser that is configured to withdraw sweep gas samples from the sweep gas outlet line 33b, and measure the fraction of CO2 and, optionally, the fraction of the at least one additional gas in the sweep gas samples at a post-oxygenator point of CO2 measurement denoted P4. The post-oxygenator point of CO2 measurement P4 is separated in distance from the point of post-oxygenator sweep gas flow rate measurements, P3, at least by the length of a post-oxygenator sample line 34b. In other embodiments, the post-oxygenator gas analyser 31b may be a so called mainstream gas analyser that is configured to measure the fraction of CO2 and, optionally, the fraction of the at least one additional gas within the sweep gas outlet line 33b. In some embodiments, the post-oxygenator gas analyser comprises at least a CO2 sensor and an 02 sensor for measuring a fraction of CO2 and 02, respectively, in the sweep gas samples. In some embodiments, the 002 sensor is an I R spectrometer for IR spectroscopy, such as IR absorption spectroscopy. In some embodiments, the 02 sensor is a paramagnetic 02 sensor. a post-oxygenator temperature sensor 31c for measuring a temperature of the output sweep gas. In some embodiments, the ECMO device 5 may further comprise or be connected to a pre-oxygenator blood gas analyser 32 for measuring a partial pressure of at least CO2 in the input bloodstream, PC02j n . The pre-oxygenator blood gas analyser 32 may also be configured to measure a partial pressure of 02 in the input bloodstream, P02j n . The pre-oxygenator blood gas analyser 32 may also be configured to measure a haemoglobin content of the input bloodstream, Hbm. In some embodiments, the blood gas analyser 32 is not incorporated into the ECMO device 5 but arranged to form part of another medical device that is connected to the ECMO device 5 in order for the ECMO device 5 to receive measurements obtained by the blood gas analyser. For example, the blood gas analyser may form part of a stand-alone blood gas analyser unit, often referred to as a BGA, commonly used for intermittent blood gas analysis during ECMO treatments.

With simultaneous reference to previous drawings, some functions and features of the ECMO-vent system 1 will now be described with reference to the flowcharts shown in Figs. 3-6, which flowcharts illustrate methods for controlling CO2 removal in and by the ECMO device 5. Unless stated otherwise, each method is a computer- implemented method that is performed by the ECMO device 5 upon execution of a computer program by at least one processor 37 of the control computer 27. The computer program(s) comprise computer-readable instructions that may be stored in a storage medium of the ECMO-vent system 1 , such as a non-transitory hardware memory device 39 of the control computer 27.

Fig. 3 is a flowchart illustrating a method for controlling CO2 removal in and by the ECMO device according to a first aspect of the present disclosure.

In a first step, S1 , CO2 is added to the sweep gas flow upstream of the oxygenator 25 in order to control a degree of CO2 removal from the bloodstream by the oxygenator 21 . CO2 is added to the sweep gas flow via the manually, semi- automatically or automatically controlled sweep gas regulator 25.

In a second step, S2, a measure of CO2 removal by the oxygenator 21 is determined based on a difference (ACCO2biood) between a measure of a pre- oxygenator content of CO2 (CCO2j n ) in the bloodstream upstream of the oxygenator 21 and an estimate of a post-oxygenator content of CO2 (CCO2 ou t) in the bloodstream downstream of the oxygenator 21. The determination is made by the control computer 27 based on sensor data obtained by the sensors 29a-29d, 31a- 31c and 32.

In a third step, S3, the measure of CO2 removal is utilized for improved regulation of the CO2 addition to the sweep gas flow.

In some embodiments, the measure of CO2 removal is determined from preoxygenator measurements of partial pressures of CO2 (PC02j n ) and 02 (P02j n ) in the input bloodstream, e.g., obtained by the blood gas analyser 32, and postoxygenator measurements of fractions of CO2 (FCO2 ou t) and 02 (FO2 ou t) in the output sweep gas flow, e.g., obtained by the post-oxygenator gas analyser 31 b.

The measure of the pre-oxygenator content of 002, CC02j n , in the input bloodstream may be expressed as a function of a pre-oxygenator partial pressure of 002 (PC02jn) of the bloodstream, a pre-oxygenator partial pressure of 02 (P02j n ) of the bloodstream, a pre-oxygenator temperature (Tm.biood) of the bloodstream, and a pre-oxygenator haemoglobin concentration (Hbm) of the bloodstream. Likewise, the estimate of the post-oxygenator content of 002, CC02 0 ut, in the output bloodstream may be expressed as a function of a post-oxygenator partial pressure of 002 (PC02 0 ut) of the bloodstream, a post-oxygenator partial pressure of 02 (PO2 ou t) of the bloodstream, a post-oxygenator temperature of the bloodstream (T ou t.biood), and a post-oxygenator haemoglobin concentration (Hb ou t) of the bloodstream. PC02j n and P02jn may be measured by the pre-oxygenator blood gas analyser 32, whereas PC02 0 ut and PO2 ou t can be assumed to substantially correspond to measured postoxygenator fractions of C02 (FCO2 ou t) and 02 (FO2 ou t) in the outlet sweep gas flow. Since the Hb concentration of the bloodstream can be assumed to be constant, Hbm and Hbout are cancelled out and the difference between the estimates of CC02j n and CCO2out can be calculated from FC02in, F02in, FCO2out, FO2out, Tin.biood and Tout.biood-

Fig. 4 is a flowchart illustrating a non-limiting example of how the determination of the measure of C02 removal in step S2 in Fig. 3 can be achieved in more detail. As illustrated in Fig. 4, step S2 may comprise the following sub-steps:

S2a) measuring a pre-oxygenator partial pressure of CO2 (PC02j n ) in the bloodstream upstream of the oxygenator 21 , e.g., by means of the pre- oxygenator blood gas analyser 32,

S2b) measuring a pre-oxygenator partial pressure of 02 (P02j n ) in the bloodstream upstream of the oxygenator 21 , e.g., by means of the pre- oxygenator blood gas analyser 32,

S2c) measuring a post-oxygenator fraction of CO2 (FCO2 ou t) in the sweep gas flow downstream of the oxygenator 21 , e.g., by means of the postoxygenator gas analyser 31b,

S2d) measuring a post-oxygenator fraction of 02 (FO2 ou t) in the sweep gas flow downstream of the oxygenator 21 , e.g., by means of the post-oxygenator gas analyser 31b,

S2e) estimating a post-oxygenator partial pressure of CO2 (PCO2 ou t) and a postoxygenator partial pressure of 02 (PO2 ou t) in the bloodstream downstream of the oxygenator 21 based on FCO2 ou t and FO2 ou t,

S2f) measuring or estimating a pre-oxygenator temperature (Tm.biood) of blood in the bloodstream upstream of the oxygenator 21. Tm.biood may be measured with a pre-oxygenator blood temperature sensor (not shown), or it may be estimated e.g. based on an assumed and/or measured temperature of the patient 3, a temperature of the sweep gas flow, a length of tubing of the blood flow channel 19, and/or an effect of a heater (not shown) for heating blood in the blood flow channel,

S2g) measuring or estimating a post-oxygenator temperature (T ou t,biood) of blood in the bloodstream downstream of the oxygenator 21 . T ou t,biood may be measured with a post-oxygenator blood temperature sensor (not shown), or it may be estimated e.g. based on an assumed and/or measured temperature of the patient 3, a temperature of the sweep gas flow, a length of tubing of the blood flow channel 19, and/or an effect of a heater (not shown) for heating blood in the blood flow channel.

S2h) measuring or estimating a haemoglobin content (Hb) of blood in the bloodstream through of the oxygenator 21 , e.g., by means of the pre- oxygenator blood gas analyser 32, and S2i) determining the difference ACCO2biood between CCO2j n and CCO2 ou t from the measured and/or estimated quantities. PC02j n , P02j n , Tin.biood, PCO2 ou t, PO2 O ut, Tout, blood, and Hb.

As illustrated by dashed lines in Fig. 4, the steps of measuring or estimating Tin.biood, Tout, blood and Hb are optional. Since, for some cases and some oxygenator configurations, Tin.biood can be assumed to substantially correspond to T ou t,biood, and since Hb is constant upstream and downstream of the oxygenator 21 , the difference ACCO2biood between CC02j n and CCO2 ou t can be approximated from PC02j n , P02j n , PCO2 O ut, and PO2 ou t alone. However, to further improve accuracy in the determination, Tin.biood and T ou t,biood may be taken into account. By determining and utilising Hb in the determination of the difference ACCO2biood, the difference can be quantified and an actual net CO2 exchange, VCO2 ne t, can be calculated and used as a measure of CO2 exchange over the oxygenator 21 .

Fig. 5 is a flowchart illustrating some non-limiting examples of how the determined measure of CO2 removal can be utilized in step S3 in Fig. 3 in order to improve regulation of the CO2 addition to the sweep gas flow.

As illustrated in Fig. 5, step S3 may comprise one or more of the following steps: S3a) presenting the measure of CO2 removal to an operator of the ECMO device 5 as decision support in manual adjustment of the addition of CO2 to the sweep gas flow. The measure of CO2 removal may, for example, be presented on a display comprised in or connected to the ECMO device 5. S3b) presenting, to the operator of the ECMO device 5, a recommendation for adjustment of the addition of CO2 to the sweep gas flow, based on the measure of CO2 removal and a set target for CO2 removal by the oxygenator. For example, the recommendation may be presented on a display comprised in or connected to the ECMO device 5. The recommendation may, for example, be a recommendation to increase or decrease the addition of CO2 to the sweep gas flow, e.g., by manually increasing or decreasing a set value for the fraction of CO2 (FC02j n ) in the sweep gas flow upstream of the oxygenator 21 . S3c) automatically regulating the addition of CO2 to the sweep gas flow based on the measure of CO2 removal and a set target for CO2 removal. For example, if the set target is zero CO2 removal, the control computer 27 may be configured to control the sweep gas regulator 25 to regulate the fraction of CO2 in the inlet sweep gas flow so as to reach and/or maintain zero CO2 removal.

Fig. 6 is a flowchart illustrating a method for controlling CO2 removal in and by the ECMO device 5 according to a second aspect of the present disclosure.

In a first optional step, S11 , CO2 is added to the sweep gas flow upstream of the oxygenator 21 to control a degree of CO2 removal from the bloodstream of the patient 3 by the oxygenator 21 .

In a second step, S12, a net CO2 exchange (VCO2 ne t) over the membrane 23 of the oxygenator 21 is calculated.

Step S12 comprises the following sub-steps:

S12a) measuring a pre-oxygenator fraction of CO2 (FC02j n ) in the sweep gas flow upstream of the oxygenator 21 , e.g., by means of the pre-oxygenator gas analyser 29b;

S12b) measuring a pre-oxygenator sweep gas flow rate (Vm) of the sweep gas flow upstream of the oxygenator 21 , e.g., by means of the pre-oxygenator flow rate sensor 29a;

S12c) measuring a post-oxygenator fraction of CO2 (FCO2 ou t) in the sweep gas flow downstream of the oxygenator 21 , e.g., by means of the postoxygenator gas analyser 31 b;

S12d) measuring a post-oxygenator sweep gas flow rate (V ou t) of the sweep gas flow downstream of the oxygenator 21 , e.g., by means of a post-oxygenator flow rate sensor 31a, and

S12e) calculating VCO2 ne t over the membrane 23 based on measured FC02j n , Vm, FCO2 O ut and V ou t. In a third optional step, S13, VCO2 ne t is utilized as a measure of CO2 removal for improved regulation of the CO2 addition to the sweep gas flow. Step S13 may comprise any of, or any combination of, the steps S3a-S3c illustrated in Fig. 5, using the calculated VCO2 ne t as the measure of CO2 removal.

The step of measuring the post-oxygenator sweep gas flow rate (V ou t) in step S12d is advantageously performed by measuring the post-oxygenator sweep gas flow rate as a flow rate of a whole effluent flow of sweep gas leaving the oxygenator. Measuring the flow rate of the whole effluent flow of sweep gas is important for precise calculation of VCO2net. In most oxygenators, sweep gas is discharged to atmosphere after having passed through the oxygenator. Some oxygenators have more than one outlet for discharge of sweep gas, e.g., as a precautionary measure should one or more oxygenator outlets be occluded during operation. In such a scenario, in order to be able to measure the flow rate of the whole effluent flow of sweep gas leaving the oxygenator, it may be desired to prevent sweep gas from leaving the oxygenator via all but one of the plurality of outlets. Consequently, in cases where the oxygenator comprises more than one outlet for sweep gas, the method may comprise the steps of preventing the sweep gas to pass through all but one outlet of the oxygenator, and measuring the post-oxygenator sweep gas flow rate as the flow rate of the sweep gas flowing through said one outlet. Prevention of sweep gas flow through one or more additional outlets of the oxygenator can be achieved by temporarily or permanently occluding the one or more additional outlets, e.g., by plugging the one or more additional outlets using silicon plugs or the like.

VCO2net may be calculated as the fraction of CO2 (FC02j n ) in the input sweep gas flow times the input sweep gas flow rate (V n ), minus the fraction of CO2 (FCO2 ou t) in the output sweep gas flow times the output sweep gas flow rate (V ou t), in accordance with:

VCO2net = (FCO2 in * V in ) - (FCO2 ou t * Vout) eq. 1

Of course, in order to accurately calculate the flow of CO2 going into and out from the oxygenator 21 , the terms FC02j n and FCO2 ou t should reflect the true fractions of CO2 at the points of measurements of V n and V ou t. Due to the humid environment (often close to 100% RH) downstream the oxygenator, there is often a need for conditioning (e.g., drying) the sweep gas before it enters the gas analyser, e.g., to prevent condensation of water inside the gas analyser. Therefore, with reference again made to Fig. 2, the ECMO device 5 may comprise a water vapour trap or gas sample conditioner (not shown) for conditioning and especially for drying the sweep gas samples withdrawn from the sweep gas outlet line 33b before the sweep gas samples enter the post-oxygenator gas analyser 31b. The gas sample conditioner may, e.g., comprise a piece of Nafion tubing or silica gel. Due to the removal of water by the gas sample conditioner, the composition of the sweep gas samples measured upon is not the same as the composition of the sweep gas flow in the sweep gas outlet line 33b, where V ou t is measured. Therefore, the fraction of CO2, FCO2 O ut, measured by the sidestream post-oxygenator gas analyser 31b at the point of measurement P4 will not accurately reflect the fraction of CO2 at the point, P3, of output sweep gas flow rate measurements.

To this end, the method may further comprise the steps of: calculating a compensated pre-oxygenator fraction of CO2 (FCO2j n ,comp) representing an estimate of a fraction of CO2 at the point of measurement, P1 , of Vin, based on FC02j n and an estimated addition or removal of water vapour, AFH2Oin, to or from the sweep gas between the point of measurement, P1 , of V in and a point of measurement, P2, of FC02j n , and/or calculating a compensated post-oxygenator fraction of CO2 (FCO2 O ut,com P ) representing an estimate of a fraction of CO2 at a point of measurement, P3, of Vout, based on FCO2 ou t and an estimated addition or removal of water vapour (AFH2O O ut) to or from the sweep gas between the point of measurement, P3, of Vout and a point of measurement, P4, of FCO2 ou t, and calculating VCO2 ne t based on n and V ou t, and at least one of FC02j n , comp and FCO2 O ut ,comp-

For example, a compensated post-oxygenator fraction of CO2 (FCO2 O ut,com P ) can be calculated as a function of measured post-oxygenator fraction of CO2 (FCO2 ou t) and an estimated addition or removal of water vapour (AFH2O ou t) to or from the sweep gas between the point of measurement, P3, of V ou t and a point of measurement, P4, of FCO2 O ut, and used in the determination of VCO2 ne t according to: FCO2 O ut ,comp f (FCO2 ou t, AFH2O O ut) eq. 2

VCO2net (FCO2in * Vjn) - (FCO2out,comp * Vout) e . 3

The estimated addition or removal of water vapour, AFH2O ou t, may, in some embodiments, be calculated based on: a measured post-oxygenator temperature (Tout, gas), measured by the post-oxygenator temperature sensor 31c; a measured or estimated post-oxygenator relative humidity (RH ou t) of the sweep gas flow downstream of the oxygenator; a measured or estimated reference temperature (Tret) at or close to the point of measurement P4 of FCO2 ou t, and; a measured or estimated reference relative humidity (RH re t) at or close to the point of measurement P4 of FCO2 O ut. In embodiments where the gas sample conditioner comprises a piece of Nation tubing, the reference relative humidity, RH re f, can be assumed to correspond to the relative humidity of the air surrounding the Nation tubing. In embodiments where the gas sample conditioner comprises silica gel, the reference relative humidity, RH re f, can be assumed to be zero or near zero. The postoxygenator relative humidity, RH ou t can in most situations be assumed to be 100% but may, in some embodiments, be measured by a humidity sensor (not shown) of the ECMO device 5, arranged downstream of the oxygenator 21 .

Another potential source of error in the calculation of VCO2 ne t is inaccuracy in sweep gas flow rate measurements. The flow sensors 29a and 31a for measuring n and Vout are normally calibrated for a specific gas composition and deviations between an assumed composition and an actual composition of the sweep gas measured upon introduces errors in flow rate determinations. Therefore, the method may further comprise the steps of: measuring or estimating a pre-oxygenator fraction of at least one additional gas in the sweep gas flow upstream of the oxygenator 21 , the at least one additional gas being one or more of water vapour (H2O), 02, nitrogen gas (N2), and an anaesthetic agent, and/or measuring or estimating a post-oxygenator fraction of the at least one additional gas in the sweep gas flow downstream of the oxygenator, and calculating a compensated pre-oxygenator sweep flow rate (V .comp) based on Vin, FCO2 in and the pre-oxygenator fraction of the at least one additional gas, and/or calculating a compensated post-oxygenator sweep flow rate (V ou t,com P ) based on Vout, FCO2 O ut and the post-oxygenator fraction of the at least one additional gas, and calculating VCO2 ne t based on FC02j n , FCO2 ou t and at least one of Vm.comp and Vout, comp-

By taking the composition of the sweep gas into account and compensating the pre- oxygenator and/or the post-oxygenator sweep flow rate measurements V and V ou t based on a measured fraction of at least one additional gas in the sweep gas flow upstream and/or downstream the oxygenator, a more accurate value of VCO2 ne t can be obtained.

For example, a compensated post-oxygenator sweep gas flow rate, Vout, comp, may be calculated as a function of V ou t, FCO2 ou t and a post-oxygenator fraction of 02, water vapour and/or N2, according to:

Vout, comp = f (Vout, FC02 0 ut, F02 0 ut, FH20 0 ut, FN2 0u t), eq. 4 where FCO2 ou t and FO2 ou t are the fractions of CO2 and 02 measured by the sidestream post-oxygenator gas analyser 31b, FH2O ou t is the fraction of water vapour in the sweep gas flow downstream of the oxygenator, which may be determined from the measured post-oxygenator temperature, T ou t, g as, of the sweep gas flow downstream of the oxygenator and the measured or estimated postoxygenator relative humidity, RH ou t, of the sweep gas flow downstream of the oxygenator, and FN2 0u t is the post-oxygenator fraction of N2 which may be measured by the post-oxygenator gas analyser 31b or be assumed to correspond to the remaining fraction of the post-oxygenator sweep gas flow.

VCO2net may then be calculated as:

VCO2net = (FCO2 in * V in ) - (FC02 0 ut ,comp * Vout, comp) eq. 5 As discussed above, there is often a need for using a gas sample conditioner for drying the gas samples between the sweep gas sampling point in the sweep gas outlet line 33b and the sidestream post-oxygenator gas analyser 31 b. The removal or reduction of water vapour content by the gas sample conditioner introduces a deviation between the composition of the sweep gas in the sweep gas outlet line (where V ou t is measured) and the sweep gas samples measured upon by the sidestream gas analyser 31 b. Therefore, to further improve accuracy in the determination of the compensated post-oxygenator sweep gas flow rate, Vout, comp, the compensated post-oxygenator fraction of CO2, FCO2 O ut,com P , may be advantageously used instead of the measured post-oxygenator fraction of CO2, FCO2 O ut, in the determination of V ou t,com P , in accordance with:

Vout, comp = f (Vout, FCO2 O ut,comp, FO2 O ut, FH2O O ut, FN2 0u t) eq. 6

Any fractions of additional gases measured by the post-oxygenator sidestream gas analyser 31 b, such as measured fractions of 02 (FO2 ou t) and/or measured fractions of N2 (FN2 0 ut), may also be compensated based on the estimated addition or removal of water vapour, AFH2O ou t, to or from the sweep gas between the point of measurement, P3, of V ou t and the point of measurement, P4, of the additional gas by the gas analyser. A compensated fraction of the additional gas may be calculated as a function of the measured fraction of the additional gas and the estimated addition or removal of water vapour, AFH2O ou t, in accordance with:

FO2out,com P = f (F02 0 ut, AFH2O O ut) eq. 7

FN2out,com P = f (FN2 0 ut, AFH2O O ut) eq. 8

The compensated fractions of the additional gases may then replace the measured fractions of additional gases in eq. 6 to further improve the accuracy in postoxygenator sweep gas flow rate determination, in accordance with:

Vout, comp = f (Vout, FC02 0 ut ,comp, F02 0 ut ,comp, FH20 0 ut, FN2out,com P ) eq. 9 A precise measure of VCO2 ne t may then be calculated using eq. 5 with a Vout.comp value calculated in accordance with eq. 9.

It should be noted that although described herein as techniques for controlling removal of CO2 from the bloodstream of a patient, the techniques of the first and second aspects of the present disclosure could as well be used to control an addition of CO2 to the bloodstream of the patient via the oxygenator 21. This may sometimes be desired to obtain or maintain a desired pH or partial pressure of CO2 (PCO2) in the blood of the patient 3. Consequently, it should be realised that the disclosed methods for controlling CO2 removal in the ECMO device 5 could be generalised to methods for controlling transfer of CO2 to or from the bloodstream of the patient 3, via the oxygenator 21 , in order to control addition or removal of CO2 to or from the blood of the patient. The purpose of controlling CO2 transfer may be any of: 1) ensuring sufficient removal of CO2 from the blood of the patient; 2) keeping CO2 removal constant, e.g., in order to evaluate an ongoing respiratory treatment provided by the mechanical ventilator 7 and/or a lung function of the patient 3, and 3) obtaining or maintaining a set or desired post-oxygenator pH and/or PCO2, in particular during adjustments of the sweep gas flow rate.

In applications where CO2 transfer over the oxygenator membrane 23 is controlled to obtain or maintain a set or desired post-oxygenator pH and/or PCO2, the control computer 27 of the ECMO device 5 may be configured to automatically control the inlet sweep gas flow rate and/or the addition of CO2 to the inlet sweep gas flow to obtain or maintain pH and/or PCO2.